Contact Information
815 West 5th North Street , Morristown, Tennessee 37814, United States
Detailed Information
Cherokee Health Systems
-
Services:
- No formal relationship with prescribing entity
- In-network prescribing entity
- Male
- Female
- Family counseling
- Smoking/vaping/tobacco cessation counseling
- Group counseling
- Individual counseling
- Substance use disorder education
- Marital/couples counseling
- Health education services other than HIV/AIDS or hepatitis
- HIV or AIDS education, counseling, or support
- Hepatitis education, counseling, or support
- This facility administers/prescribes medication for alcohol use disorder
- Telemedicine/telehealth therapy
- Relapse prevention
- Anger management
- Motivational interviewing
- Brief intervention
- Cognitive behavioral therapy
- Substance use disorder counseling
- Trauma-related counseling
- Hepatitis A (HAV) vaccination
- Hepatitis B (HBV) vaccination
- Buprenorphine used in Treatment
- Naltrexone used in Treatment
- Substance use treatment
- Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
- Smoking permitted in designated area
- Testing for Hepatitis C (HCV)
- TB screening
- Testing for Hepatitis B (HBV)
- STD testing
- Metabolic syndrome monitoring
- Drug or alcohol urine screening
- HIV testing
- Regular outpatient treatment
- Outpatient
- Housing services
- Recovery coach
- Mentoring/peer support
- Assistance with obtaining social services
- Screening for substance use
- Complete medical history/physical exam
- Comprehensive substance use assessment
- Screening for mental disorders
- Screening for tobacco use
- Comprehensive mental health assessment
- Sliding fee scale (fee is based on income and other factors)
- Does not treat opioid use disorders
- Young Adults
- Adults
- Clients with co-occurring mental and substance use disorders
- Buprenorphine with naloxone
- Nicotine replacement
- Medications for Hepatitis C treatment
- Naltrexone (oral)
- Acamprosate (CampralĀ®)
- Naltrexone (extended-release, injectable)
- Medication for mental disorders
- Medications for pre-exposure to prophylaxis
- Disulfiram
- Non-nicotine smoking/tobacco cessation
- Buprenorphine (extended-release, injectable)
- Buprenorphine without naloxone
- Treatment for other addiction disorder
- Naloxone and overdose education
- Aftercare/continuing care
- State mental health department
- Federally Qualified Health Center
- State Substance use treatment agency
- Integrated primary care services
- Case management service
- Early intervention for HIV
- Mental health services
- Transportation assistance
- Private non-profit organization
- Medicare
- Federal military insurance (e.g., TRICARE)
- State-financed health insurance plan other than Medicaid
- Federal, or any government funding for substance use treatment programs
- Cash or self-payment
- Medicaid
- SAMHSA funding/block grants
- Private health insurance
- Sign language services for the deaf and hard of hearing
- Vaping permitted in designated area
External Source of Medications Used for Alcohol Use Disorder Treatment
Gender Accepted
Education and Counseling Services
Type of Alcohol Use Disorder Treatment
Treatment Approaches
Medical Services
Opioid Medications used in Treatment
Type of Care
Facility Smoking Policy
Testing
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Recovery Support Services
Assessment/Pre-treatment
Payment Assistance Available
Type of Opioid Treatment
Age Groups Accepted
Special Programs/Groups Offered
Pharmacotherapies
Other Services
Transitional Services
License/Certification/Accreditation
Ancillary Services
Facility Operation (e.g., Private, Public)
Payment/Insurance/Funding Accepted
Language Services
Facility Vaping Policy
Opening Hours
Monday
6:00 am - 10:00 pm
Tuesday
6:00 am - 10:00 pm
Wednesday
6:00 am - 10:00 pm
Thursday
6:00 am - 10:00 pm
Friday
6:00 am - 10:00 pm
Saturday
6:00 am - 10:00 pm
Sunday
6:00 am - 10:00 pm